Literature DB >> 6871876

Promoting effects of sodium L-ascorbate on two-stage urinary bladder carcinogenesis in rats.

S Fukushima, K Imaida, T Sakata, T Okamura, M Shibata, N Ito.   

Abstract

The promoting effect of sodium L-ascorbate on two-stage urinary bladder carcinogenesis in F344 rats initiated with N-butyl-N-(4-hydroxybutyl)nitrosamine at levels of 0.01 and 0.05% in drinking water was studied. Administration of 5.0% but not of 1.0% sodium L-ascorbate in the diet significantly increased the incidence and number of preneoplastic lesions, papillary or nodular hyperplasia, papilloma, and cancer of the urinary bladder. In groups given 5.0% sodium L-ascorbate, the urine was characterized by an apparent elevation of pH, a decrease of osmolality, and an increase of MgNH4PO4 crystalline. Addition of sodium L-ascorbate to the diet also resulted in increase in the content of ascorbic acid and its metabolite, dehydroascorbic acid, in the urine. These results show that an extremely high dose of sodium L-ascorbate (5.0%) promotes urinary bladder carcinogenesis under the present experimental conditions, while a high dose (1.0%) does not.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6871876

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  17 in total

Review 1.  Chemoprevention of bladder cancer.

Authors:  Dragan J Golijanin; David Kakiashvili; Ralph R Madeb; Edward M Messing; Seth P Lerner
Journal:  World J Urol       Date:  2006-11       Impact factor: 4.226

2.  Dose-response study of urinary bladder carcinogenesis in rats by N-butyl-N-(4-hydroxybutyl)nitrosamine.

Authors:  N Ito; T Shirai; S Fukushima; M Hirose
Journal:  J Cancer Res Clin Oncol       Date:  1984       Impact factor: 4.553

3.  Hydroxylation of deoxyguanosine at the C-8 position by ascorbic acid and other reducing agents.

Authors:  H Kasai; S Nishimura
Journal:  Nucleic Acids Res       Date:  1984-02-24       Impact factor: 16.971

4.  Promoting effect of sodium chloride in 2-stage urinary bladder carcinogenesis in rats initiated by N-butyl-N-(4-hydroxybutyl)nitrosamine.

Authors:  M A Shibata; K Nakanishi; M Shibata; T Masui; Y Miyata; N Ito
Journal:  Urol Res       Date:  1986

5.  Pathobiology and chemoprevention of bladder cancer.

Authors:  Takuji Tanaka; Katsuhito Miyazawa; Tetsuya Tsukamoto; Toshiya Kuno; Koji Suzuki
Journal:  J Oncol       Date:  2011-09-15       Impact factor: 4.375

6.  Strain differences in sensitivity to the promoting effect of sodium L-ascorbate in a two-stage rat urinary bladder carcinogenesis model.

Authors:  T Murai; S Mori; M Hosono; A Takashima; S Machino; T Oohara; H Yamashita; S Makino; T Matsuda; H Wanibuchi; S Fukushima
Journal:  Jpn J Cancer Res       Date:  1997-03

7.  Structure-activity relations in promotion of rat urinary bladder carcinogenesis by phenolic antioxidants.

Authors:  Y Kurata; S Fukushima; R Hasegawa; M Hirose; M Shibata; T Shirai; N Ito
Journal:  Jpn J Cancer Res       Date:  1990-08

Review 8.  Cell proliferation not associated with carcinogenesis in rodents and humans.

Authors:  J M Ward; H Uno; Y Kurata; C M Weghorst; J J Jang
Journal:  Environ Health Perspect       Date:  1993-12       Impact factor: 9.031

9.  Biochemical changes associated with ascorbic acid-cisplatin combination therapeutic efficacy and protective effect on cisplatin-induced toxicity in tumor-bearing mice.

Authors:  Amenla Longchar; Surya Bali Prasad
Journal:  Toxicol Rep       Date:  2015-02-07

10.  Synergism of environmental carcinogens and promoters on bladder cancer development initiated by N-butyl-N-(4-hydroxybutyl)nitrosamine in F344 rats.

Authors:  S Ono; Y Kurata; Y Shichino; M Sano; S Fukushima
Journal:  Jpn J Cancer Res       Date:  1992-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.